Pluristem Therapeutics, Inc. News Headlines

PSTI 
$2.46
*  
unch
unch
Get PSTI Alerts
*Delayed - data as of Dec. 24, 2014  -  Find a broker to begin trading PSTI now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    PSTI Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Formation Of A New Expert Group Moves Pluristem Into The Expansive Hematology Field
12/5/2012 6:59:00 PM - Seeking Alpha


Maxim Group Highlights 3 Stem Cells Stocks To Consider And 1 To Avoid
12/4/2012 10:03:00 AM - Seeking Alpha


Orphan Status Update from Pluristem - Analyst Blog
11/27/2012 6:00:01 PM - Zacks.com


4 Undervalued And Technically Oversold Healthcare Penny Stocks Poised To Bounce
11/20/2012 9:58:00 AM - Seeking Alpha


An Exciting Week In Cell Therapy
11/12/2012 3:57:00 AM - Seeking Alpha


$33,000 Portfolio: Mostly Cash Ahead Of Elections And Snow-Hurricanes
10/30/2012 10:20:00 AM - Seeking Alpha


Dilution Is The Solution To Pollution
10/9/2012 12:24:00 PM - Seeking Alpha


5 Bio-Pharmas On The Rise With Potential Groundbreaking And Lifesaving Treatments
10/9/2012 9:45:00 AM - Seeking Alpha


Mr. Market's Stem Cell Roulette
10/5/2012 11:54:00 AM - Seeking Alpha


Tracking Recent Buy Calls And Investments By The Maxim Group
9/28/2012 8:55:00 AM - Seeking Alpha


Whatever you Do, Don't Sell This Surging Stock
9/18/2012 1:00:00 PM - David Sterman


The 20 Most Popular Stocks On Seeking Alpha Over The Last Month
9/13/2012 7:54:00 PM - Seeking Alpha


Buy or Sell? Thursday's Losers: Pluristem (Nasdaq: PLSTM) and FirstMerit (Nasdaq: FMER)
9/13/2012 8:45:00 AM - David Sterman


Biotech: On The Way To Meeting Highly Ambitious Expectations
9/10/2012 11:41:00 AM - Seeking Alpha


Stem Cell Therapy: The Black And White Therapies Of The Space
9/10/2012 3:54:00 AM - Seeking Alpha


Orphan Status Sought for PSTI Drug - Analyst Blog
8/31/2012 4:32:48 PM - Zacks.com


Pluristem to Begin IC Phase II Trial - Analyst Blog
8/24/2012 5:30:01 PM - Zacks.com


Pluristem-BCRT Alliance Extended - Analyst Blog
8/22/2012 6:32:12 PM - Zacks.com


Pluristem Gets Green Light in India - Analyst Blog
8/20/2012 6:32:06 PM - Zacks.com


Pluristem Vs. Geron: An Insider's View Of The Stem Cell Story
12/19/2011 3:45:00 AM - Seeking Alpha


InVivo's Innovative Instigation In Spinal Cord Injury
11/11/2011 1:17:00 PM - Seeking Alpha


Biotechs Placing Bets On Cell Therapy Success
10/7/2011 10:50:00 AM - Seeking Alpha


6 Biotech Penny Stocks to Buy
6/24/2011 1:00:42 AM - Louis Navellier


Competition Between Aastrom Bio and Pluristem Heating Up
4/18/2011 12:27:00 PM - Seeking Alpha


Agencies Agree to Consider Consider Clinical Studies Proposal for Pluristem Pipeline
1/18/2011 8:27:00 PM - Seeking Alpha